Ovensa Inc.
Alexandre Moquin is a highly experienced scientist with a diverse background in pharmaceutical sciences and product development. Currently a Senior Scientist at Oligo Medic since June 2021, Alexandre also serves as a Product Development Scientist at Ovensa Inc. since May 2018. Prior to these roles, Alexandre was a postdoctoral researcher at McGill University from August 2014 to February 2020, managing multiple projects from conception to publication while also handling grant writing and laboratory procurement. Alexandre holds a PhD in Pharmaceutical Sciences and a Bachelor of Science in Biochemistry, both from Université de Montréal.
This person is not in the org chart
This person is not in any offices
Ovensa Inc.
Ovensa provides nanomedicine technology platforms, which deliver targeted oral therapy with mucosal and brain-barrier crossing properties. Ovensa focuses on developing personalized treatments for cancer and neurodegenerative diseases and on preventing antibiotic resistance.